ArticlePloS one2024

AP39, a novel mitochondria-targeted hydrogen sulfide donor ameliorates doxorubicin-induced cardiotoxicity by regulating the AMPK/UCP2 pathway.

Bin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.